EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advanced next-generation vaccines for dengue and other flaviviral infections

Gerry Amor Camer, Taichi Endoh, Kotetsu Kayama, Hiroki Teraoka, Zainab Sohail, Daiji Endoh

Journal of Vector Borne Diseases · 2026-07 · 63 (3) · 424-426

DOI: 10.4103/jvbd.jvbd_319_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Vector Borne Diseases, online erschienen am 22.09.2026. Verfasst von Gerry Amor Camer und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, University of Eastern Philippines, 6400, Catarman, Northern Samar, Philippines. Hauptthemen laut MEDLINE: Dengue, Dengue Vaccines, Flaviviridae Infections, Viral Vaccines. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Notifiable flaviviral pathogens, particularly dengue, continue to pose significant health and economic challenges worldwide, especially in tropical regions where these infections remain endemic. In the Philippines, the risk remains high following the 2019 withdrawal of the Dengvaxia vaccine, with no alternative immunization currently available locally. Recent interest in nucleic acid-based immunogens highlights the need for scalable, non-infectious vaccine production platforms; however, generating high-dose DNA constructs capable of inducing effective immune responses without live-virus propagation remains challenging. Our work from 2018 to 2024 addressed this need through the development of computationally designed, cell-free, PCR-amplifiable DNA constructs using algorithmic overlap extension PCR (OE-PCR) and an improved technique, asymmetric extension supported by a simulator for oligonucleotide extension (AESOE). Subsequent integration of machine learning, including recurrent neural network-based amplification prediction and LAMP primer design, further improved synthesis efficiency and expanded applications for surveillance and diagnostics. The AESOE-guided OE-PCR platform enabled the assembly of synthetic flaviviral DNA fragments of at least 1 kilobase in length from overlapping oligonucleotides, supporting scalable production of synthetic immunogens without the need for infectious viral materials. These live-virus-free strategies may enhance biosafety, reduce development timelines, and improve accessibility for laboratories in resource-limited settings, potentially supporting next-generation vaccine development for dengue and other flaviviral diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DengueDengue VaccinesFlaviviridae InfectionsViral VaccinesHumansDengue VirusPhilippinesPolymerase Chain ReactionVaccine DevelopmentVaccines, DNA

Stichwörter der Autor:innen

Dengue DNA vaccinePCR gene synthesisflaviviruses

Substanzen

Dengue VaccinesVaccines, DNAViral Vaccines

Autor:innen und Institutionen

  • College of Veterinary Medicine, University of Eastern Philippines, 6400, Catarman, Northern Samar, Philippines.
  • School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu, Japan.
  • College of Science, Polytechnic University of the Philippines, 1016, Manila, Philippines.
  • MATO Corporation, Shinagawa-ku, Tokyo, Japan.
  • Medical Corporation Tetsuryukai, Kasai Home Care Clinic, Edogawa-ku, Tokyo, Japan.
  • Hills Road Sixth Form College, Cambridge, United Kingdom.

Zitieren

APA

Camer, G. A., Endoh, T., Kayama, K., Teraoka, H., Sohail, Z., & Endoh, D. (2026). Advanced next-generation vaccines for dengue and other flaviviral infections. Journal of Vector Borne Diseases, 63(3), 424-426. https://doi.org/10.4103/jvbd.jvbd_319_25

Vancouver

Camer GA, Endoh T, Kayama K, Teraoka H, Sohail Z, Endoh D. Advanced next-generation vaccines for dengue and other flaviviral infections. Journal of Vector Borne Diseases. 2026;63(3):424-426. doi:10.4103/jvbd.jvbd_319_25

BibTeX
@article{Camer2026,
  author = {Camer, Gerry Amor and Endoh, Taichi and Kayama, Kotetsu and Teraoka, Hiroki and Sohail, Zainab and Endoh, Daiji},
  title = {Advanced next-generation vaccines for dengue and other flaviviral infections},
  journal = {Journal of Vector Borne Diseases},
  year = {2026},
  volume = {63},
  number = {3},
  pages = {424--426},
  doi = {10.4103/jvbd.jvbd_319_25}
}
Kostenlos starten →